Novel Immune Supportive Prevention of Malaria – Data Collection Research in the City of Bukavu (DR Congo)
Harry van der Zee (1i), DieudonneBisiboAlimasi (2ii), Joseph Ndebo Balikwisha (3iii), Harald Walach (4iv)
1) Amma Resonance Healing Foundation, Netherlands
2) Departement des Oeuvres Medicales, Communaute des Eglises Evangeliques des Amis au Congo (CEEACO), Bukavu, DR Congo
3) Amma4Africa Fondation, Goma, DR Congo
4) Next Society Institute, Kazimieras Simonavicius University, Vilnius
This study evaluates the Africa Malaria Prevention Project (AMPP), which aims to enhance immunity against malaria using PC240m, a Source Resonance developed by Peter Chappell in 2002 based on Information Medicine.
From 2019-2023, AMPP was implemented in HAs 1-5 [2019: n=16.000 (8,9% of population); 2023: n=40.121 (19.2%). HAs 6-10 introduced AMPP in 2023 [n=33.636 (20,7%)], while HAs 11-13 served as controls throughout. Baseline data from 2018 and registered malaria cases and deaths (2018-2023) were analyzed using random-effects meta-analysis, because individual level-data were not available. This restricts the validity of the data.
Results revealed significant reductions in malaria cases (odds ratio 0.55) and malaria-related deaths (odds ratio 0.61). Individuals treated with PC240m were 45% less likely to develop malaria and 39% less likely to die from it compared to controls.
Malaria Cases per 1000 (all ages)
These findings suggest PC240m might effectively enhance immunity against malaria and might offer a feasible, inexpensive, and safe prevention strategy. Further research with cluster-randomized trials and individual-level data is necessary for more precise comparisons and validation of results.
Tags: Africa ▪ Immunity ▪ Information Medicine ▪ malaria ▪ PC240m ▪ Prevention ▪ Resonance
Stories of Hope & Impact
